High-dose intravenous immunoglobulin therapy in dysimmune neuropathies

Neurol Sci. 2002 Apr:23 Suppl 1:S25-32. doi: 10.1007/s100720200012.

Authors

E Nobile-Orazio¹, A Bersano

Affiliation

¹ Giorgio Spagnol Neuroimmunology Service, Dino Ferrari Centre, Department of Neurological Sciences, Milan University, IRCCS Ospedale Maggiore Policlinico, Via Francesco Sforza 35, I-20122 Milan, Italy.

PMID: 12032584
DOI: 10.1007/s100720200012

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Dose-Response Relationship, Drug
Guillain-Barre Syndrome / drug therapy
Guillain-Barre Syndrome / immunology
Guillain-Barre Syndrome / physiopathology
Humans
Immunization, Passive / adverse effects
Immunization, Passive / methods*
Immunoglobulins, Intravenous / administration & dosage*
Immunoglobulins, Intravenous / adverse effects
Motor Neuron Disease / drug therapy
Motor Neuron Disease / immunology
Motor Neuron Disease / physiopathology
Paraproteinemias / drug therapy
Paraproteinemias / immunology
Paraproteinemias / physiopathology
Peripheral Nervous System Diseases / drug therapy*
Peripheral Nervous System Diseases / immunology
Peripheral Nervous System Diseases / physiopathology
Polyradiculoneuropathy / drug therapy*
Polyradiculoneuropathy / immunology
Polyradiculoneuropathy / physiopathology
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / immunology
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / physiopathology

Substances

Immunoglobulins, Intravenous